Table 4.
Comparison of primary and secondary outcomes between study groups per quartera
| Proportion of Hemoglobin (g/dl) | Control Group | Treatment Group | P |
|---|---|---|---|
| Quarter 1 | |||
| <10 | 17 (20.5) | 8 (10.4) | 0.07 |
| 10–12 | 62 (74.7) | 62 (80.5) | 0.29 |
| >12 | 4 (4.8) | 7 (9.1) | 0.21 |
| Quarter 2 | |||
| <10 | 25 (33.3) | 9 (13.0) | 0.002 |
| 10–12 | 47 (62.7) | 56 (81.2) | 0.03 |
| >12 | 3 (4.0) | 4 (5.8) | 0.15 |
| Quarter 3 | |||
| <10 | 19 (27.1) | 14 (20.0) | 0.21 |
| 10–12 | 48 (68.6) | 55 (78.6) | 0.13 |
| >12 | 3 (4.3) | 1 (1.4) | 0.31 |
| Quarter 4 | |||
| <10 | 22 (31.9) | 11 (16.2) | 0.03 |
| 10–12 | 39 (56.5) | 54 (79.4) | 0.003 |
| >12 | 8 (11.6) | 3 (4.4) | 0.11 |
Data are given as n (%).
a
Excludes participants who did not receive ESAs in the analyzed quarter.